Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of oral insulin capsule ORMD-0801 added to oral antihyperglycemic therapy in type 2 diabetes
ChiCTR2000038662Phase 3Recruiting
- Sponsor
- Ruijin Hospital
- Start
- Sep 2020
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ORMD-0801 in type 2 diabetes mellitus (T2DM), sponsored by Ruijin Hospital. Started Sep 2020; status: recruiting.
02
Drugs
ORMD-0801
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR2000038662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000038662.